| |
| Alle Journale wurden nach Heuberger H durchsucht |
Treffer 1 - 5 von 5 |
|
|
|---|
1. Mueck AO;
Heuberger H;
Seeger H;
Wallwiener D
Comparison of Valsartan With Candesartan on Their Possible Protection From Atherosclerosis
AII-Antagonisten - Atherosklerose
Journal of Clinical and Basic Cardiology 2001; 4 (4): 297-299
Changes in cell number of human coronary artery smooth muscle cells after addition of angiotensin II alone (10 microM), angiotensin (10 microM) + candesartan, and angiotensin (10 microM) + valsartan as percentage of control value = (100 %). (means +/- SD, triplicates from 2 different experiments, * p < 0.05, ** p < 0.01 vs A II; A II: angiotensin II; Can: candesartan; Val: valsartan) Keywords: Angiotensin II,
Angiotensin II,
Candesartan,
Candesartan,
Diagramm,
Glatte Muskelzelle,
smooth muscle cell,
Valsartan,
Valsartan
|
|
|
2. Mueck AO;
Heuberger H;
Seeger H;
Wallwiener D
Comparison of Valsartan With Candesartan on Their Possible Protection From Atherosclerosis
AII-Antagonisten - Atherosklerose
Journal of Clinical and Basic Cardiology 2001; 4 (4): 297-299
Changes in pro-MMP-1 concentration in endothelial cell cultures from human coronary artery after addition of angiotensin II alone (10 microM), angiotensin (10 microM) + candesartan, and angiotensin (10 microM) + valsartan as percentage of control value = (100 %). (means +/- SD, triplicates from 2 different experiments, * p < 0.05, ** p < 0.01 vs A II; A II = angiotensin II; Can = candesartan; Val
= valsartan) Keywords: Angiotensin II,
Angiotensin II,
Candesartan,
Candesartan,
Diagramm,
matrix-metalloproteinase,
Matrixmetalloproteinase,
pro-MMP-1,
pro-MMP-1,
Valsartan,
Valsartan
|
|
|
3. Mueck AO;
Heuberger H;
Seeger H;
Wallwiener D
Comparison of Valsartan With Candesartan on Their Possible Protection From Atherosclerosis
AII-Antagonisten - Atherosklerose
Journal of Clinical and Basic Cardiology 2001; 4 (4): 297-299
Changes in PAI-1 concentration in endothelial cell cultures from human coronary artery after addition of angiotensin II alone (10 microM), angiotensin (10 microM) + candesartan, and angiotensin (10 microM) + valsartan as percentage of control value = (100 %). (means +/- SD, triplicates from 2 different experiments, * p < 0.05, ** p < 0.01 vs A II; A II = angiotensin II; Can = candesartan; Val = valsartan) Keywords: Angiotensin II,
Angiotensin II,
Candesartan,
Candesartan,
Diagramm,
PAI-1,
PAI-1,
plasminogen activator inhibitor,
Plasminogenaktivatorinhibitor,
Valsartan,
Valsartan
|
|
|
4. Mueck AO;
Heuberger H;
Seeger H;
Wallwiener D
Comparison of Valsartan With Candesartan on Their Possible Protection From Atherosclerosis
AII-Antagonisten - Atherosklerose
Journal of Clinical and Basic Cardiology 2001; 4 (4): 297-299
Changes in endothelin concentration in endothelial cell cultures from human coronary artery after addition of angiotensin II alone (10 microM), angiotensin (10 microM) + candesartan, and angiotensin (10 microM) + valsartan as percentage of control value = (100 %). (means +/- SD, triplicates from 2 different experiments, ** p < 0.01 vs A II; A II = angiotensin II; Can = candesartan; Val = valsartan) Keywords: Angiotensin II,
Angiotensin II,
Candesartan,
Candesartan,
Diagramm,
endothelin,
endothelin,
Valsartan,
Valsartan
|
|
|
5. Mueck AO;
Heuberger H;
Seeger H;
Wallwiener D
Comparison of Valsartan With Candesartan on Their Possible Protection From Atherosclerosis
AII-Antagonisten - Atherosklerose
Journal of Clinical and Basic Cardiology 2001; 4 (4): 297-299
Changes in eNOS concentrations in endothelial cell cultures from human coronary artery after addition of angiotensin II alone (10 microM), angiotensin (10 microM) + candesartan, and angiotensin (10 microM) + valsartan as percentage of control value (= 100 %). (means +/- SD, triplicates from 2 different experiments, * p < 0.05, ** p < 0.01 vs A II; A II = angiotensin II; Can = candesartan; Val
= valsartan) Keywords: Angiotensin II,
Angiotensin II,
Candesartan,
Candesartan,
Diagramm,
Endothel,
endothelium,
eNOS,
eNOS,
Valsartan,
Valsartan
|
|
|
| |
|
Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
